| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.17 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Respiratory syncytial virus (RSV) is increasingly recognized as being implicated in acute illness in older adults, with a significant weight in hospitalizations for respiratory illness and death. By means of a best-evidence review, this paper aims to investigate whether RSV can be considered a forgotten pathogen in older patients, looking at trends in the literature volume and exploring possible epidemiological and clinical features underlying the focus given to it. We then present an assessment of its disease burden and present and future strategies for its reduction, particularly in light of the recent availability of new vaccines.
Descrição
Funding Information: This study was supported by EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT). Publisher Copyright: © 2024 by the authors.
Palavras-chave
elderly older adults pneumonia respiratory syncytial virus RSV vaccine Infectious Diseases Virology SDG 3 - Good Health and Well-being